InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Tilton Glenn F, 董事. Director active across 3 companies, notably AbbVie Inc.. In total, 14 filings have been published. Activity tracked since 7 May 2021. The latest transaction was disclosed on 15 January 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Tilton Glenn F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
1,423 股@ US$140.5618.8% 占其流量Common StockSEC:0001194624-26-000002:0
1,203 股0Common Stock, $0.01 par valueSEC:0001415889-25-012803:0
1,684 股@ US$118.776921.2% 占其流量Common StockSEC:0001534701-25-000024:0
1,322 股0Common Stock, $0.01 par valueSEC:0001415889-24-012520:0
1,524 股@ US$131.3120.0% 占其流量Common StockSEC:0001534701-24-000023:0
39.756 股@ US$92.01570.4% 占其流量Common StockSEC:0001534701-23-000109:0
1,450 股0Common Stock, $0.01 par valueSEC:0001415889-23-007677:0
1,929 股@ US$103.68520.2% 占其流量Common StockSEC:0001534701-23-000018:0
1,421 股0Common Stock, $0.01 par valueSEC:0001179110-22-002932:0
1,602 股0Common shares without par valueSEC:0001415889-22-004558:0
22,500 股Common StockSEC:0001534701-22-000086:0
2,284 股@ US$87.570.0003% mcap50.0% 占其流量Common StockSEC:0001534701-22-000006:0
1,681 股0Common Stock, $0.01 par valueSEC:0001179110-21-005208:0
2,578 股Common StockSEC:0001534701-16-000085:0
14 条申报中的 14 条
About Tilton Glenn F
Glenn F. Tilton is a Director at AbbVie Inc., Phillips 66, and ABBOTT LABORATORIES. He plays a key role in the governance and strategy of the companies.
